mRNA Bioanalysis Service
The rapid advancement of messenger RNA (mRNA) technologies has revolutionized the landscape of modern medicine, moving far beyond the initial success of prophylactic vaccines into the realms of oncology and personalized gene therapy. As part of our therapeutic nucleic acid development platform, CD BioGlyco offers a specialized mRNA bioanalysis service designed to bridge the gap between initial mRNA-based vaccine development and successful clinical outcomes.
Effective mRNA therapeutics require rigorous characterization to ensure the stability of the genetic payload, the efficiency of the lipid nanoparticle (LNP) delivery system, and the robustness of the resulting immune response. Our bioanalytical platform provides high-sensitivity quantification and functional assessment of mRNA molecules and their expressed proteins within complex biological matrices. By integrating state-of-the-art molecular biology and immunology techniques, we help researchers navigate the complexities of pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity, ensuring that every candidate meets the highest standards of safety and efficacy.
At CD BioGlyco, we provide a specialized suite of services under our therapeutic nucleic acid development platform, specifically tailored for mRNA-based vaccine development. Our mRNA bioanalysis service includes:
We collaborate with you to define the study objectives, selecting the most appropriate biomarkers and analytical methods based on your specific mRNA construct and target disease.
Whether working with serum, tissues, or purified mRNA, our team implements standardized protocols for sample extraction and stabilization to prevent RNA degradation and ensure data reproducibility.
Our scientists develop custom assays or adapt platform methods to suit your unique antigen. This stage includes meticulous validation of sensitivity, specificity, and dynamic range.
Utilizing automated liquid handling and advanced detection systems, we process samples efficiently, maintaining high precision even for large-scale samples.
Raw data is processed using proprietary bioinformatic pipelines to extract meaningful insights, such as cytokine polyfunctionality indexes or antibody maturation trends.
Every project undergoes a multi-step quality control (QC) review. We provide a comprehensive final report containing detailed methodology, raw data, and expert interpretation.
Infectious Disease Vaccines
Our services accelerate the development of mRNA vaccines against viral and bacterial pathogens by providing rapid immunogenicity readouts and efficacy data in both preclinical models and proclinical samples.
Cancer Immunotherapy
We support the characterization of neoantigen-based cancer vaccines, evaluating the ability of mRNA to induce potent, tumor-specific T cell responses and long-term immune memory in complex oncology environments.
Protein Replacement Therapy
For non-vaccine applications, we monitor the expression levels and biodistribution of mRNA-encoded functional proteins, ensuring that therapeutic thresholds are met in target tissues such as the liver or lungs.
Gene Editing Support
We provide critical bioanalytical data for mRNA-delivered gene editing systems, tracking the transient expression of nucleases and assessing any potential innate immune triggers caused by the delivery vehicle or mRNA sequence.
Exceptional Sensitivity and Precision
CD BioGlyco employs state-of-the-art detection technologies that provide low limits of detection (LOD), ensuring that even trace amounts of mRNA or low-titer antibody responses are accurately quantified and characterized.
Comprehensive Integrated Services
We offer an "all-in-one" solution that covers everything from structural integrity testing to functional immunological assays, reducing the need for multiple vendors and streamlining the entire development timeline for our clients.
Rigorous Quality Management
Our bioanalytical services are conducted following rigorous quality management systems, providing data that is suitable for preclinical research.
Highly Customizable Assays
Recognizing that every mRNA project is unique, we provide tailored assay development services that adapt to specific delivery systems, target antigens, and animal models, ensuring maximum relevance of the generated data.
Their team's ability to correlate mRNA localization with protein expression gave us the confidence we needed to move forward. The technical support was exceptional throughout the project.
— C.T., Director of Bioanalysis
CD BioGlyco managed to detect subtle immune shifts in our low-dose groups that other labs missed. Their workflow is efficient, and the final reports are of the highest quality.
— B.E., Senior Scientist
Partnering with CD BioGlyco for our neutralizing antibody assays saved us months of internal development. The data was highly reproducible across different batches. We look forward to our next collaboration.
— C.S., Head of Immunology
CD BioGlyco is your dedicated partner for comprehensive and high-precision mRNA bioanalysis service. From initial structural characterization to complex immunogenicity profiling, we provide the scientific expertise and advanced technology required to bring your mRNA therapeutics to life. Please feel free to contact us for detailed information on our services or to request a formal quotation.
